These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21299475)

  • 21. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
    Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 5-lipoxygenase inhibitor zileuton on airway responses to inhaled swine house dust in healthy subjects.
    Larsson BM; Kumlin M; Sundblad BM; Larsson K; Dahlén SE; Palmberg L
    Respir Med; 2006 Feb; 100(2):226-37. PubMed ID: 15939582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and clinical efficacy of zileuton in patients with chronic asthma.
    Lazarus SC; Lee T; Kemp JP; Wenzel S; Dubé LM; Ochs RF; Carpentier PJ; Lancaster JF
    Am J Manag Care; 1998 Jun; 4(6):841-8. PubMed ID: 10181070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.
    Awni WM; Braeckman RA; Granneman GR; Witt G; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():22-33. PubMed ID: 8620668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.
    Hui KP; Taylor IK; Taylor GW; Rubin P; Kesterson J; Barnes NC; Barnes PJ
    Thorax; 1991 Mar; 46(3):184-9. PubMed ID: 1851340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.
    Watkins PB; Dube LM; Walton-Bowen K; Cameron CM; Kasten LE
    Drug Saf; 2007; 30(9):805-15. PubMed ID: 17722971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of zileuton on theophylline pharmacokinetics.
    Granneman GR; Braeckman RA; Locke CS; Cavanaugh JH; Dubé LM; Awni WM
    Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.
    Bertrán X; Mañé J; Fernández-Bañares F; Castellá E; Bartolí R; Ojanguren I; Esteve M; Gassull MA
    Gut; 1996 Jun; 38(6):899-904. PubMed ID: 8984030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of zileuton on antipyrine and indocyanine green disposition.
    St Peter JV; Braeckman RA; Granneman GR; Locke CS; Cavanaugh JH; Awni WM
    Clin Pharmacol Ther; 1995 Mar; 57(3):299-308. PubMed ID: 7697947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor.
    Kane GC; Tollino M; Pollice M; Kim CJ; Cohn J; Murray JJ; Dworski R; Sheller J; Fish JE; Peters SP
    Prostaglandins; 1995 Jul; 50(1):1-18. PubMed ID: 8588068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep.
    Abraham WM; Ahmed A; Cortes A; Sielczak MW; Hinz W; Bouska J; Lanni C; Bell RL
    Eur J Pharmacol; 1992 Jul; 217(2-3):119-26. PubMed ID: 1330588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.
    Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Rubin P; Cohn J; White MV; Igarashi Y; Kaliner MA; Drazen JM
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):1046-56. PubMed ID: 7798537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD.
    Gompertz S; Stockley RA
    Chest; 2002 Jul; 122(1):289-94. PubMed ID: 12114372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans.
    Awni WM; Hussein Z; Cavanaugh JH; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():92-7. PubMed ID: 8620677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.